(Q33747793)

English

Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Ji-Yuan Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Chun-Hui Song

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Feng Shi

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Zheng Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jun-Liang Fu

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Fu-Sheng Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

e13869

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

copyright license

Creative Commons Attribution 4.0 International

8 November 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Interplay between pathogenic Th17 and regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

IL-17 family cytokines and the expanding diversity of effector T cell lineages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

21 June 2018

Hepatitis B Virus Infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Cutting edge: programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-specific CD8+ T cells in acute self-limited hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

The interleukin-17 pathway is involved in human alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013869

21 January 2018

Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

30 October 2018

Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2975625

30 October 2018

Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/21079784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-17 as a new marker of severity of acute hepatic injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/21079784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/21079784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0013869

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2010PLoSO...513869Z

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33747793&oldid=1869899247"